Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Targeting IGF2BP3 Enhances Anti-Leukemic Effects of Menin-MLL Inhibition in MLL-AF4 Leukemia
Home
Publications
Targeting IGF2BP3 Enhances Anti-Leukemic Effects of Menin-MLL Inhibition in MLL-AF4 Leukemia
Targeting IGF2BP3 Enhances Anti-Leukemic Effects of Menin-MLL Inhibition in MLL-AF4 Leukemia
Authors:
TL
Tasha L. Lin
Tasha L. Lin
AR
Alexander J. Ritter
Alexander J. Ritter
AJ
Amit K. Jaiswal
Amit K. Jaiswal
JR
Jenna Reppas
Jenna Reppas
TT
Tiffany M. Tran
Tiffany M. Tran
ZN
Zachary T. Neeb
Zachary T. Neeb
SK
Sol Katzman
Sol Katzman
MT
Michelle Thaxton
Michelle Thaxton
AC
Amanda Cohen
Amanda Cohen
JS
Jeremy R. Sanford
Jeremy R. Sanford
DR
Dinesh S. Rao
Dinesh S. Rao
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
2 November 2023
journal article
abstracts
Published by
American Society of Hematology
in
Blood
Vol. 142
(Supplement)
,
5692
DOI:
10.1182/blood-2023-174813
Abstract
Disclosures. Rao:AbbVie, Inc: Consultancy, Speakers Bureau.
Keywords
LEUKEMIA DISCLOSURES
ENHANCES ANTI-LEUKEMIC
TARGETING
ANTI-LEUKEMIC EFFECTS
MENIN-MLL INHIBITION
SPEAKERS BUREAU
ENHANCES
LEUKEMIA
DISCLOSURES
CONSULTANCY
Related articles
Scroll to top